Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.28 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.20.
Market Cap
8.28T
Revenue
4.59T
Profits
200.87B
PE Ratio
41.20
Profit Margin
4.37%
Dividend Yield
0.43%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 897.72B | -0.89% | 1,751,335 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 555.59B | 0.16% | 7,001,505 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 372.39B | 1.09% | 5,005,378 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 362.43B | -0.52% | 5,342,488 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 287.29B | -1.47% | 1,027,755 | 60.44B |
| 6 | NVS | Novartis AG | 284.82B | 0.01% | 1,521,771 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 280.10B | -0.04% | 5,283,243 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 207.87B | -2.72% | 13,291,515 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.47B | -0.07% | 2,041,477 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 166.56B | 0.49% | 2,100,392 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 163.96B | -0.74% | 4,533,203 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 151.60B | -0.97% | 2,171,191 | 10.58B |
| 13 | ABT | Abbott Laboratories | 147.88B | 1.28% | 11,018,206 | 45.13B |
| 14 | PFE | Pfizer Inc. | 146.76B | -0.81% | 24,102,665 | 63.32B |
| 15 | CVS | CVS Health Corporation | 123.96B | -0.98% | 9,299,363 | 405.62B |
| 16 | SYK | Stryker Corporation | 117.12B | 1.13% | 3,178,318 | 25.27B |
| 17 | DHR | Danaher Corporation | 116.46B | -0.87% | 4,208,822 | 24.78B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.93B | 0.67% | 7,686,868 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 114.32B | -0.58% | 1,088,229 | 12.22B |
| 20 | SNY | Sanofi | 102.61B | 1.01% | 1,752,746 | 54.60B |
| 21 | GSK | GSK plc | 100.77B | -0.06% | 3,536,040 | 43.29B |
| 22 | MDT | Medtronic plc | 98.82B | 1.00% | 7,443,474 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.99B | 1.21% | 933,365 | 76.39B |
| 24 | MCK | McKesson Corporation | 89.82B | 1.36% | 933,527 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 86.15B | -0.73% | 1,720,665 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 79.59B | 0.92% | 14,590,127 | 20.61B |
| 27 | CI | The Cigna Group | 78.02B | -1.92% | 1,409,765 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.53B | -0.97% | 751,858 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.51B | -0.06% | 3,543,913 | 28.34B |
| 30 | MDLN | Medline Inc. | 51.10B | 0.49% | 4,360,940 | 29.14B |
| 31 | COR | Cencora, Inc. | 50.80B | 2.12% | 3,385,304 | 328.68B |
| 32 | ARGX | argenx SE | 50.39B | 2.42% | 197,215 | 4.74B |
| 33 | EW | Edwards Lifesciences Corporation | 46.84B | -0.06% | 3,312,544 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 45.52B | 4.31% | 3,623,433 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 42.03B | 0.79% | 786,069 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 41.12B | -2.59% | 5,522,595 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 39.81B | 0.20% | 2,778,633 | 22.23B |
| 38 | HLN | Haleon plc | 39.40B | -1.22% | 6,690,282 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.18B | 0.68% | 889,662 | 4.29B |
| 40 | HUM | Humana Inc. | 36.18B | -1.15% | 2,036,950 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 33.87B | -3.77% | 261,905 | 5.70B |
| 42 | WAT | Waters Corporation | 32.72B | -0.51% | 1,089,568 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 32.01B | 0.46% | 1,502,655 | 7.07B |
| 44 | RVMD | Revolution Medicines, Inc. | 31.78B | -0.31% | 1,804,796 | - |
| 45 | ZTS | Zoetis Inc. | 31.64B | 1.53% | 8,712,552 | 9.53B |
| 46 | ALC | Alcon Inc. | 30.92B | 0.88% | 1,515,129 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 30.75B | 0.28% | 3,513,436 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.37B | 0.34% | 931,243 | 5.54B |
| 49 | CNC | Centene Corporation | 28.99B | -0.19% | 5,851,738 | 178.33B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 28.51B | 1.26% | 4,515,558 | 20.98B |
| 51 | IQV | IQVIA Holdings Inc. | 28.49B | -0.99% | 1,687,577 | 16.63B |
| 52 | BIIB | Biogen Inc. | 28.25B | -6.43% | 2,812,934 | 9.94B |
| 53 | NTRA | Natera, Inc. | 28.20B | 0.81% | 1,382,173 | 2.50B |
| 54 | VEEV | Veeva Systems Inc. | 25.50B | 0.33% | 1,681,389 | 3.20B |
| 55 | INSM | Insmed Incorporated | 25.06B | -2.01% | 2,761,442 | 819.56M |
| 56 | PHG | Koninklijke Philips N.V. | 24.51B | -0.51% | 908,736 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.44B | -0.65% | 373,619 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.26B | -0.26% | 646,501 | 3.23B |
| 59 | DXCM | DexCom, Inc. | 22.31B | -1.28% | 4,318,027 | 4.82B |
| 60 | ILMN | Illumina, Inc. | 21.67B | -1.21% | 2,008,081 | 4.39B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.21B | -0.73% | 700,467 | 3.22B |
| 62 | STE | STERIS plc | 21.18B | 2.31% | 1,004,317 | 5.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 21.11B | 0.96% | 2,914,285 | 13.31M |
| 64 | MTD | Mettler-Toledo International Inc. | 21.05B | 1.60% | 291,083 | 4.09B |
| 65 | LH | Labcorp Holdings Inc. | 20.83B | -0.16% | 540,476 | 14.14B |
| 66 | DGX | Quest Diagnostics Incorporated | 20.80B | -1.52% | 768,064 | 11.28B |
| 67 | VTRS | Viatris Inc. | 20.10B | -0.63% | 7,842,131 | 14.56B |
| 68 | MRNA | Moderna, Inc. | 19.85B | -0.77% | 7,668,123 | 2.23B |
| 69 | INCY | Incyte Corporation | 19.50B | -1.20% | 1,350,202 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 17.10B | 1.37% | 1,515,026 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.20B | 1.32% | 1,519,832 | 3.90B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 15.99B | -1.41% | 1,285,135 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 15.99B | -0.08% | 2,170,730 | 8.41B |
| 74 | ASND | Ascendis Pharma A/S | 15.25B | 0.78% | 278,119 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.50B | -0.55% | 695,886 | 4.44B |
| 76 | SMMT | Summit Therapeutics Inc. | 14.08B | -3.46% | 1,971,829 | - |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.64B | 1.53% | 2,236,877 | 579.96M |
| 78 | RGC | Regencell Bioscience Holdings Limited | 13.31B | -1.50% | 39,943 | - |
| 79 | GH | Guardant Health, Inc. | 13.08B | 0.19% | 1,164,453 | 1.08B |
| 80 | SOLV | Solventum Corporation | 12.89B | 0.01% | 1,791,324 | 8.26B |
| 81 | EXEL | Exelixis, Inc. | 12.84B | -0.37% | 2,420,733 | 2.38B |
| 82 | SNN | Smith & Nephew plc | 12.71B | -0.34% | 990,360 | 6.16B |
| 83 | PEN | Penumbra, Inc. | 12.70B | 0.12% | 346,104 | 1.45B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | -2.47% | 1,718,500 | 1.06B |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | 4.05% | 343,568 | 1.13B |
| 86 | DVA | DaVita Inc. | 12.36B | -2.79% | 867,708 | 13.84B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.01B | 3.36% | 1,852,435 | 13.65B |
| 88 | MEDP | Medpace Holdings, Inc. | 11.97B | -1.08% | 252,365 | 2.68B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 11.95B | -1.30% | 572,430 | 708.24M |
| 90 | COO | The Cooper Companies, Inc. | 11.78B | 1.53% | 2,180,089 | 4.15B |
| 91 | FMS | Fresenius Medical Care AG | 11.60B | 0.37% | 1,296,905 | 22.32B |
| 92 | ALGN | Align Technology, Inc. | 11.50B | -0.75% | 633,645 | 4.10B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.34B | 3.85% | 3,673,183 | 3.58B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.22B | 2.32% | 1,799,276 | 622.01M |
| 95 | ELAN | Elanco Animal Health Incorporated | 10.81B | -0.73% | 4,739,201 | 4.89B |
| 96 | RVTY | Revvity, Inc. | 10.75B | 1.44% | 967,498 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.64B | -0.18% | 927,889 | 6.07B |
| 98 | GMED | Globus Medical, Inc. | 10.48B | 2.17% | 1,705,898 | 3.10B |
| 99 | ENSG | The Ensign Group, Inc. | 10.39B | 0.71% | 786,385 | 5.27B |
| 100 | UHS | Universal Health Services, Inc. | 10.33B | -0.20% | 813,609 | 17.76B |
| 101 | PODD | Insulet Corporation | 10.30B | -0.11% | 1,699,038 | 2.90B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.29B | -0.58% | 1,158,855 | 3.24B |
| 103 | CYTK | Cytokinetics, Incorporated | 9.79B | 1.84% | 2,349,096 | 105.82M |
| 104 | MOH | Molina Healthcare, Inc. | 9.73B | -2.69% | 719,118 | 43.10B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.63B | -0.38% | 249,383 | 7.46M |
| 106 | ABVX | ABIVAX Société Anonyme | 9.57B | -0.75% | 692,134 | 5.37M |
| 107 | MASI | Masimo Corporation | 9.34B | -0.03% | 585,725 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.32B | 1.19% | 375,689 | 417.30M |
| 109 | BAX | Baxter International Inc. | 9.18B | 2.72% | 5,340,500 | 11.32B |
| 110 | ICLR | ICON Public Limited Company | 8.94B | -0.25% | 1,185,035 | 8.10B |
| 111 | IBRX | ImmunityBio, Inc. | 8.54B | - | 9,402,569 | 140.98M |
| 112 | GKOS | Glaukos Corporation | 8.35B | 3.54% | 536,297 | 551.35M |
| 113 | HSIC | Henry Schein, Inc. | 8.27B | 4.55% | 3,120,705 | 13.38B |
| 114 | NUVL | Nuvalent, Inc. | 8.25B | -0.77% | 303,776 | - |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.21B | -1.17% | 1,454,846 | 1.51B |
| 116 | TEM | Tempus AI, Inc. | 8.17B | -0.92% | 6,257,080 | 1.36B |
| 117 | PCVX | Vaxcyte, Inc. | 7.73B | -1.35% | 1,363,664 | - |
| 118 | CRL | Charles River Laboratories International, Inc. | 7.66B | -2.29% | 829,204 | 4.03B |
| 119 | ATR | AptarGroup, Inc. | 7.53B | 0.09% | 531,018 | 3.87B |
| 120 | TECH | Bio-Techne Corporation | 7.00B | -0.33% | 3,425,767 | 1.21B |
| 121 | OSCR | Oscar Health, Inc. | 6.97B | -1.99% | 9,790,642 | 13.30B |
| 122 | HQY | HealthEquity, Inc. | 6.95B | 0.17% | 783,477 | 1.31B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 6.95B | -1.27% | 327,465 | 51.48M |
| 124 | MIRM | Mirum Pharmaceuticals, Inc. | 6.79B | 2.04% | 1,032,370 | 569.61M |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 6.79B | 1.61% | 413,740 | 74.06M |
| 126 | QGEN | Qiagen N.V. | 6.76B | 1.80% | 3,312,819 | 2.10B |
| 127 | BRKR | Bruker Corporation | 6.72B | 0.71% | 1,902,384 | 3.46B |
| 128 | BIO | Bio-Rad Laboratories, Inc. | 6.59B | 1.13% | 403,534 | 2.59B |
| 129 | GRFS | Grifols, S.A. | 6.57B | 1.04% | 495,522 | 8.58B |
| 130 | SYRE | Spyre Therapeutics, Inc. | 6.57B | -0.86% | 449,788 | - |
| 131 | CELC | Celcuity Inc. | 6.51B | 8.23% | 2,425,864 | - |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.42B | -0.10% | 754,351 | 217.17M |
| 133 | ALKS | Alkermes plc | 6.39B | -1.41% | 1,739,882 | 1.56B |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.29B | 0.22% | 843,451 | 1.55B |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.29B | -0.04% | 606,992 | - |
| 136 | PACS | PACS Group, Inc. | 6.28B | -4.00% | 1,224,337 | 5.43B |
| 137 | CORT | Corcept Therapeutics Incorporated | 6.26B | 2.14% | 1,879,054 | 769.10M |
| 138 | SRRK | Scholar Rock Holding Corporation | 6.14B | 2.21% | 2,205,841 | - |
| 139 | CGON | CG Oncology, Inc. | 6.13B | -6.03% | 1,250,503 | 5.07M |
| 140 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 1,621,898 | 15.00M |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.03B | -1.01% | 591,006 | 827.11M |
| 142 | BLTE | Belite Bio, Inc | 5.90B | -2.33% | 148,811 | - |
| 143 | IMVT | Immunovant, Inc. | 5.89B | -0.99% | 1,218,854 | - |
| 144 | COGT | Cogent Biosciences, Inc. | 5.84B | -0.29% | 1,246,377 | - |
| 145 | RGEN | Repligen Corporation | 5.83B | -3.41% | 2,029,169 | 763.34M |
| 146 | BLCO | Bausch + Lomb Corporation | 5.80B | 0.12% | 428,524 | 5.21B |
| 147 | TGTX | TG Therapeutics, Inc. | 5.78B | -4.36% | 1,542,228 | 700.35M |
| 148 | TFX | Teleflex Incorporated | 5.77B | 0.18% | 557,697 | 2.13B |
| 149 | CHE | Chemed Corporation | 5.63B | 0.51% | 233,640 | 2.54B |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.61B | 0.41% | 18,274,473 | 2.37B |
| 151 | AVTR | Avantor, Inc. | 5.42B | 0.89% | 11,138,188 | 6.55B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | 0.21% | 1,367,058 | 7.50M |
| 153 | LEGN | Legend Biotech Corporation | 5.29B | -0.24% | 2,223,728 | 1.14B |
| 154 | LQDA | Liquidia Corporation | 5.27B | 2.97% | 1,577,439 | 288.07M |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | - | - | 1.11B |
| 156 | STVN | Stevanato Group S.p.A. | 4.91B | 0.73% | 366,432 | 1.39B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.87B | -4.36% | 1,664,202 | 4.10M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.67B | -0.47% | 241,399 | 1.34M |
| 159 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.50B | -0.98% | 410,052 | 754.05M |
| 160 | SHC | Sotera Health Company | 4.42B | 0.06% | 4,036,833 | 1.19B |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.39B | -1.01% | 136,793 | 274.48M |
| 162 | MANE | Veradermics, Incorporated | 4.37B | -1.00% | 347,634 | - |
| 163 | CAI | Caris Life Sciences, Inc. | 4.31B | 3.81% | 3,809,872 | 907.29M |
| 164 | NAMS | NewAmsterdam Pharma Company N.V. | 4.24B | -2.30% | 1,297,912 | 22.57M |
| 165 | RDNT | RadNet, Inc. | 4.20B | 0.85% | 720,567 | 2.14B |
| 166 | HNGE | Hinge Health, Inc. | 4.17B | -0.33% | 2,117,475 | 646.34M |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.10B | -1.01% | 3,051,899 | 536.20M |
| 168 | BLLN | BillionToOne, Inc. | 4.04B | -2.93% | 501,266 | 354.54M |
| 169 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.04B | 2.21% | 1,285,198 | 18.07M |
| 170 | LIVN | LivaNova PLC | 3.94B | -1.06% | 386,414 | 1.43B |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 3.90B | -1.29% | 1,879,948 | 3.05B |
| 172 | NVST | Envista Holdings Corporation | 3.88B | -0.25% | 2,945,199 | 2.81B |
| 173 | ORKA | Oruka Therapeutics, Inc. | 3.85B | 1.14% | 1,084,411 | - |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | - | 4,128,578 | 596.96M |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -0.41% | 2,029,032 | 1.10B |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.75B | -0.44% | 370,856 | 787.85M |
| 177 | MMSI | Merit Medical Systems, Inc. | 3.73B | -0.10% | 998,445 | 1.54B |
| 178 | VKTX | Viking Therapeutics, Inc. | 3.68B | 0.03% | 1,434,152 | - |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | 0.74% | 837,259 | - |
| 180 | TLX | Telix Pharmaceuticals Limited | 3.64B | 3.23% | 106,336 | 803.79M |
| 181 | WAY | Waystar Holding Corp. | 3.61B | 0.75% | 2,820,465 | 1.16B |
| 182 | TNGX | Tango Therapeutics, Inc. | 3.60B | -2.51% | 5,401,768 | 56.99M |
| 183 | WRBY | Warby Parker Inc. | 3.55B | 1.44% | 2,745,714 | 890.57M |
| 184 | OGN | Organon & Co. | 3.51B | 0.15% | 3,938,784 | 6.16B |
| 185 | ALHC | Alignment Healthcare, Inc. | 3.42B | -9.36% | 9,502,693 | 4.26B |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 3.35B | 1.28% | 874,355 | 2.23B |
| 187 | DOCS | Doximity, Inc. | 3.33B | -23.00% | 25,491,388 | 644.86M |
| 188 | TWST | Twist Bioscience Corporation | 3.30B | -2.65% | 915,090 | 409.48M |
| 189 | ERAS | Erasca, Inc. | 3.22B | -0.86% | 3,298,745 | - |
| 190 | BKD | Brookdale Senior Living Inc. | 3.15B | 2.72% | 3,667,416 | 3.00B |
| 191 | RCUS | Arcus Biosciences, Inc. | 3.14B | -0.20% | 695,220 | 236.00M |
| 192 | ALMS | Alumis Inc. | 3.13B | -0.93% | 507,020 | 8.40M |
| 193 | OPCH | Option Care Health, Inc. | 3.13B | 0.86% | 5,184,488 | 5.67B |
| 194 | MMED | MiniMed Group, Inc. | 3.11B | -0.89% | 471,810 | 2.99B |
| 195 | VCYT | Veracyte, Inc. | 3.10B | 1.70% | 902,960 | 541.74M |
| 196 | NHC | National HealthCare Corporation | 3.09B | 1.67% | 55,635 | 1.53B |
| 197 | GMRS | GMR Solutions Inc. | 3.09B | -0.93% | 3,084,864 | 5.74B |
| 198 | DNLI | Denali Therapeutics Inc. | 3.08B | -2.07% | 1,828,143 | - |
| 199 | ICUI | ICU Medical, Inc. | 3.07B | 0.78% | 210,089 | 2.16B |
| 200 | LFST | LifeStance Health Group, Inc. | 3.06B | -2.59% | 5,260,994 | 1.49B |
| 201 | ITGR | Integer Holdings Corporation | 3.05B | 0.48% | 364,215 | 1.86B |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.02B | -0.87% | 913,112 | - |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.97B | -0.31% | 558,690 | 776.83M |
| 204 | BEAM | Beam Therapeutics Inc. | 2.94B | -7.28% | 2,424,202 | 164.01M |
| 205 | PRVA | Privia Health Group, Inc. | 2.93B | 2.73% | 1,246,205 | 2.25B |
| 206 | VERA | Vera Therapeutics, Inc. | 2.84B | 1.05% | 1,016,944 | - |
| 207 | GPCR | Structure Therapeutics Inc. | 2.83B | 4.62% | 825,642 | - |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | 0.80% | 603,920 | 535.08M |
| 209 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 1.85% | 340,389 | - |
| 210 | HTFL | HeartFlow, Inc. | 2.78B | 3.33% | 1,436,965 | 176.03M |
| 211 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.08% | 1,393,710 | 285.01M |
| 212 | TXG | 10x Genomics, Inc. | 2.73B | 2.14% | 2,783,082 | 638.78M |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.70B | -0.55% | 1,865,777 | 415.62M |
| 214 | IRON | Disc Medicine, Inc. | 2.66B | -0.47% | 560,845 | - |
| 215 | HAE | Haemonetics Corporation | 2.65B | 0.19% | 789,076 | 1.33B |
| 216 | GRAL | GRAIL, Inc. | 2.65B | 2.20% | 644,776 | 156.12M |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -1.10% | 562,597 | - |
| 218 | NBTX | Nanobiotix S.A. | 2.61B | 5.82% | 142,426 | 38.27M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -0.18% | 576,699 | 865.00K |
| 220 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.21% | 749,965 | 225.27M |
| 221 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | -2.49% | 1,161,356 | 670.00M |
| 222 | NKTR | Nektar Therapeutics | 2.51B | -2.13% | 788,732 | 55.63M |
| 223 | IMNM | Immunome, Inc. | 2.49B | -0.81% | 603,759 | 4.02M |
| 224 | ACHC | Acadia Healthcare Company, Inc. | 2.46B | -1.29% | 2,234,207 | 3.37B |
| 225 | RLAY | Relay Therapeutics, Inc. | 2.45B | -3.33% | 4,381,440 | 10.68M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | -0.31% | 5,326,912 | 885.72M |
| 227 | KOD | Kodiak Sciences Inc. | 2.42B | -2.30% | 474,241 | - |
| 228 | DFTX | Definium Therapeutics, Inc. | 2.33B | -3.00% | 1,087,076 | - |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.30B | 1.68% | 355,242 | 1.46B |
| 230 | ZLAB | Zai Lab Limited | 2.28B | -0.68% | 1,054,779 | 453.28M |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.27B | 1.35% | 272,788 | 256.28M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | 1.53% | 708,515 | - |
| 233 | AXGN | Axogen, Inc. | 2.18B | 1.64% | 681,903 | 238.11M |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.17B | -11.35% | 2,468,183 | 1.09B |
| 235 | HCM | HUTCHMED (China) Limited | 2.17B | -0.63% | 25,079 | 548.51M |
| 236 | TYRA | Tyra Biosciences, Inc. | 2.17B | 0.88% | 534,456 | - |
| 237 | TMDX | TransMedics Group, Inc. | 2.14B | -3.33% | 1,579,899 | 635.89M |
| 238 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -1.24% | 1,311,797 | - |
| 239 | ADPT | Adaptive Biotechnologies Corporation | 2.11B | 0.38% | 1,600,077 | 295.41M |
| 240 | NVCR | NovoCure Limited | 2.09B | -0.28% | 1,560,709 | 674.41M |
| 241 | XRAY | DENTSPLY SIRONA Inc. | 2.09B | -0.29% | 3,848,202 | 3.68B |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.08B | 2.81% | 2,842,967 | 52.04M |
| 243 | ESTA | Establishment Labs Holdings Inc. | 2.05B | 1.04% | 279,812 | 229.58M |
| 244 | SEM | Select Medical Holdings Corporation | 2.04B | -0.06% | 1,523,723 | 5.52B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -1.19% | 948,084 | 298.30M |
| 246 | BHC | Bausch Health Companies Inc. | 2.04B | 3.02% | 1,474,832 | 10.53B |
| 247 | PHVS | Pharvaris N.V. | 2.01B | -6.80% | 480,649 | - |
| 248 | OMCL | Omnicell, Inc. | 1.99B | 1.46% | 438,441 | 1.23B |
| 249 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -0.85% | 3,284,753 | 2.18B |
| 250 | GENB | Generate Biomedicines, Inc. | 1.97B | -4.62% | 326,205 | 30.30M |
| 251 | ADMA | ADMA Biologics, Inc. | 1.97B | - | 3,317,734 | 509.86M |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.95B | -1.07% | 533,855 | 32.08M |
| 253 | ASTH | Astrana Health, Inc. | 1.94B | -1.51% | 337,205 | 3.53B |
| 254 | SION | Sionna Therapeutics, Inc. | 1.93B | -0.81% | 342,366 | - |
| 255 | MESO | Mesoblast Limited | 1.92B | 2.38% | 285,650 | 65.38M |
| 256 | AAPG | Ascentage Pharma Group International | 1.88B | -5.61% | 9,189 | 82.08M |
| 257 | MD | Pediatrix Medical Group, Inc. | 1.88B | -2.09% | 1,075,757 | 1.93B |
| 258 | SGRY | Surgery Partners, Inc. | 1.88B | 1.19% | 3,435,589 | 3.34B |
| 259 | PLSE | Pulse Biosciences, Inc. | 1.85B | 13.11% | 1,215,871 | 751.00K |
| 260 | CLOV | Clover Health Investments, Corp. | 1.84B | -1.69% | 11,486,214 | 2.21B |
| 261 | NEOG | Neogen Corporation | 1.83B | -3.05% | 3,255,805 | 870.56M |
| 262 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -2.31% | 130,546 | 1.20B |
| 263 | NTLA | Intellia Therapeutics, Inc. | 1.83B | -8.33% | 14,166,235 | 66.09M |
| 264 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -1.63% | 2,322,867 | 217.17M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -0.34% | 207,853 | 20.00M |
| 266 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -5.55% | 1,853,637 | 7.47M |
| 267 | ANAB | AnaptysBio, Inc. | 1.81B | -0.80% | 469,373 | 232.39M |
| 268 | SNDA | Sonida Senior Living, Inc. | 1.80B | -0.52% | 743,947 | 367.34M |
| 269 | VRDN | Viridian Therapeutics, Inc. | 1.80B | 2.29% | 2,120,587 | 70.92M |
| 270 | PGNY | Progyny, Inc. | 1.79B | -2.72% | 1,211,922 | 1.29B |
| 271 | OCS | Oculis Holding AG | 1.79B | -3.67% | 243,127 | 1.40M |
| 272 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -0.23% | 518,428 | 899.11M |
| 273 | QURE | uniQure N.V. | 1.75B | -4.87% | 1,515,614 | 18.09M |
| 274 | ZYME | Zymeworks Inc. | 1.75B | -2.48% | 557,688 | 81.26M |
| 275 | AHG | Akso Health Group | 1.75B | 5.70% | 227,258 | 14.84M |
| 276 | CAPR | Capricor Therapeutics, Inc. | 1.73B | -1.71% | 865,100 | 11.13M |
| 277 | UFPT | UFP Technologies, Inc. | 1.71B | 0.78% | 116,675 | 608.85M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | -0.14% | 611,502 | 66.05M |
| 279 | PVLA | Palvella Therapeutics, Inc. | 1.71B | -1.33% | 157,108 | - |
| 280 | INBX | Inhibrx Biosciences, Inc. | 1.70B | -1.52% | 292,900 | 1.30M |
| 281 | VCEL | Vericel Corporation | 1.69B | 0.91% | 453,202 | 292.09M |
| 282 | ADUS | Addus HomeCare Corporation | 1.69B | -2.22% | 357,385 | 1.45B |
| 283 | INVA | Innoviva, Inc. | 1.69B | -1.21% | 633,943 | 420.69M |
| 284 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | -1.66% | 223,753 | 923.71M |
| 285 | MBX | MBX Biosciences, Inc. | 1.68B | -5.71% | 839,976 | - |
| 286 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -1.11% | 529,073 | 71.78M |
| 287 | NUVB | Nuvation Bio Inc. | 1.64B | -1.26% | 3,077,466 | 143.05M |
| 288 | PGEN | Precigen, Inc. | 1.64B | 10.84% | 9,730,900 | 31.60M |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.62B | 9.90% | 4,276,483 | 2.52B |
| 290 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | -0.33% | 15,009,906 | 66.41M |
| 291 | ARDX | Ardelyx, Inc. | 1.60B | 1.25% | 2,075,751 | 427.68M |
| 292 | STAA | STAAR Surgical Company | 1.59B | 8.88% | 4,064,208 | 290.38M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -1.48% | 530,246 | 42.95M |
| 294 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | -3.83% | 12,614,581 | 285.61M |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.56B | -2.17% | 225,499 | 74.21M |
| 296 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.54B | -4.80% | 845,932 | -665.00K |
| 297 | NVAX | Novavax, Inc. | 1.54B | 1.30% | 4,610,176 | 596.34M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.57% | 1,555,673 | 65.50M |
| 299 | ENOV | Enovis Corporation | 1.50B | 1.63% | 680,519 | 2.28B |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.50B | 2.65% | 1,410,191 | 322.02M |
| 301 | PRGO | Perrigo Company plc | 1.50B | -0.64% | 2,845,043 | 4.18B |
| 302 | IMTX | Immatics N.V. | 1.50B | 3.52% | 308,864 | 43.00M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.48B | 0.49% | 372,408 | 1.85B |
| 304 | ATAI | AtaiBeckley Inc. | 1.48B | -4.72% | 2,885,265 | 3.49M |
| 305 | ARDT | Ardent Health, Inc. | 1.48B | 4.14% | 308,677 | 6.43B |
| 306 | PAHC | Phibro Animal Health Corporation | 1.47B | 2.52% | 544,979 | 1.50B |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.46B | -1.97% | 350,980 | 20.00M |
| 308 | IMCR | Immunocore Holdings plc | 1.46B | -0.66% | 151,903 | 412.81M |
| 309 | URGN | UroGen Pharma Ltd. | 1.45B | -4.07% | 825,732 | 140.49M |
| 310 | DMRA | Damora Therapeutics, Inc. | 1.44B | -1.16% | 194,402 | - |
| 311 | CMPS | COMPASS Pathways plc | 1.43B | -3.10% | 4,482,781 | - |
| 312 | AHCO | AdaptHealth Corp. | 1.43B | -0.65% | 1,247,173 | 3.29B |
| 313 | ATRC | AtriCure, Inc. | 1.43B | 5.87% | 638,516 | 552.16M |
| 314 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.15% | 3,471,693 | 73.62M |
| 315 | SLS | SELLAS Life Sciences Group, Inc. | 1.38B | 13.63% | 16,800,580 | - |
| 316 | GHRS | GH Research PLC | 1.38B | 1.51% | 166,385 | - |
| 317 | BHVN | Biohaven Ltd. | 1.36B | -0.11% | 1,642,166 | - |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.36B | -1.62% | 1,294,913 | - |
| 319 | FTRE | Fortrea Holdings Inc. | 1.35B | -1.67% | 1,036,574 | 2.71B |
| 320 | ABCL | AbCellera Biologics Inc. | 1.34B | -7.76% | 7,372,192 | 79.21M |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.34B | -0.11% | 692,089 | - |
| 322 | SVRA | Savara Inc. | 1.34B | - | 1,315,512 | - |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -4.27% | 275,888 | - |
| 324 | WVE | Wave Life Sciences Ltd. | 1.33B | -1.29% | 3,169,551 | 71.80M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.32B | -1.76% | 274,758 | - |
| 326 | AGL | agilon health, inc. | 1.31B | 9.00% | 442,552 | 5.82B |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.29B | 2.89% | 260,202 | 83.72M |
| 328 | PNTG | The Pennant Group, Inc. | 1.28B | 3.68% | 305,289 | 1.02B |
| 329 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.68% | 178,225 | - |
| 330 | SEPN | Septerna, Inc. | 1.28B | 14.42% | 556,102 | 72.26M |
| 331 | COAG | Hemab Therapeutics Holdings, Inc. | 1.25B | -0.67% | 157,626 | - |
| 332 | INSP | Inspire Medical Systems, Inc. | 1.23B | 1.77% | 2,352,116 | 915.25M |
| 333 | OLMA | Olema Pharmaceuticals, Inc. | 1.21B | 1.77% | 1,164,628 | - |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.19B | -5.17% | 510,725 | 10.00M |
| 335 | TDOC | Teladoc Health, Inc. | 1.19B | -2.65% | 3,039,343 | 2.51B |
| 336 | JBIO | Jade Biosciences, Inc. | 1.19B | -3.75% | 149,187 | - |
| 337 | AMN | AMN Healthcare Services, Inc. | 1.18B | -1.85% | 1,315,309 | 3.42B |
| 338 | DBVT | DBV Technologies S.A. | 1.17B | 1.28% | 174,956 | 5.74M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.16B | 0.26% | 2,917,051 | 787.08M |
| 340 | IVA | Inventiva S.A. | 1.16B | 0.18% | 137,235 | 7.94M |
| 341 | AVNS | Avanos Medical, Inc. | 1.16B | -0.04% | 1,061,813 | 715.90M |
| 342 | WGS | GeneDx Holdings Corp. | 1.15B | -0.23% | 1,481,662 | 442.68M |
| 343 | HROW | Harrow, Inc. | 1.15B | 3.45% | 1,129,400 | 268.68M |
| 344 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | -13.79% | 3,946,300 | - |
| 345 | NNNN | Anbio Biotechnology | 1.14B | 2.61% | 10,012 | 8.65M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -0.11% | 259,686 | 796.33M |
| 347 | IART | Integra LifeSciences Holdings Corporation | 1.13B | -2.72% | 942,726 | 1.64B |
| 348 | AORT | Artivion, Inc. | 1.11B | 3.15% | 758,524 | 458.69M |
| 349 | IRMD | IRADIMED CORPORATION | 1.11B | 1.90% | 72,756 | 86.28M |
| 350 | EYPT | EyePoint, Inc. | 1.11B | -1.41% | 514,832 | 7.61M |
| 351 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.11B | -1.83% | 1,539,836 | 204.73M |
| 352 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | -0.78% | 1,492,185 | 314.85M |
| 353 | CNMD | CONMED Corporation | 1.09B | 2.22% | 399,947 | 1.37B |
| 354 | NEO | NeoGenomics, Inc. | 1.09B | 1.21% | 1,019,477 | 745.97M |
| 355 | AKTS | Aktis Oncology, Inc. | 1.08B | -0.15% | 114,565 | 8.28M |
| 356 | ALVO | Alvotech | 1.07B | -6.54% | 342,349 | 562.04M |
| 357 | BFLY | Butterfly Network, Inc. | 1.07B | 4.59% | 3,540,456 | 102.92M |
| 358 | CDNA | CareDx, Inc. | 1.06B | -0.58% | 470,301 | 412.82M |
| 359 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 3.90% | 1,674,924 | 204.89M |
| 360 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -4.51% | 2,521,221 | 69.64M |
| 361 | BLFS | BioLife Solutions, Inc. | 1.03B | -0.43% | 262,097 | 101.66M |
| 362 | CRON | Cronos Group Inc. | 1.03B | 0.37% | 1,250,870 | 159.54M |
| 363 | INNV | InnovAge Holding Corp. | 1.01B | 0.54% | 318,813 | 949.17M |
| 364 | MNKD | MannKind Corporation | 994.82M | 0.31% | 3,592,242 | 360.78M |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 992.55M | -1.10% | 771,611 | - |
| 366 | USPH | U.S. Physical Therapy, Inc. | 990.59M | 8.23% | 495,731 | 787.69M |
| 367 | OMDA | Omada Health, Inc. | 985.66M | 3.37% | 1,644,561 | 283.30M |
| 368 | EVO | Evotec SE | 975.16M | 0.18% | 47,867 | 859.03M |
| 369 | TNDM | Tandem Diabetes Care, Inc. | 969.69M | 0.28% | 2,770,767 | 1.03B |
| 370 | OMER | Omeros Corporation | 961.14M | -7.65% | 3,446,003 | 9.89M |
| 371 | SDGR | Schrödinger, Inc. | 942.98M | -1.02% | 1,062,301 | 254.91M |
| 372 | PHAR | Pharming Group N.V. | 929.08M | -0.08% | 12,619 | 369.49M |
| 373 | PCRX | Pacira BioSciences, Inc. | 925.86M | 2.13% | 438,988 | 734.86M |
| 374 | MGTX | MeiraGTx Holdings plc | 921.46M | -0.20% | 904,081 | 79.76M |
| 375 | DRTS | Alpha Tau Medical Ltd. | 916.18M | 7.99% | 1,029,230 | - |
| 376 | DSGN | Design Therapeutics, Inc. | 908.12M | -6.91% | 296,986 | - |
| 377 | LBRX | LB Pharmaceuticals Inc | 900.73M | -2.79% | 77,171 | - |
| 378 | GERN | Geron Corporation | 898.13M | -0.71% | 18,612,268 | 196.12M |
| 379 | SPTX | Seaport Therapeutics, Inc. | 895.90M | 2.39% | 380,275 | - |
| 380 | INMD | InMode Ltd. | 890.19M | 0.07% | 978,765 | 374.64M |
| 381 | BVS | Bioventus Inc. | 886.30M | 2.02% | 401,315 | 576.30M |
| 382 | XNCR | Xencor, Inc. | 880.80M | -4.04% | 527,665 | 97.36M |
| 383 | ANNX | Annexon, Inc. | 879.83M | -1.47% | 1,588,011 | - |
| 384 | NUTX | Nutex Health Inc. | 879.71M | -3.08% | 87,636 | 879.95M |
| 385 | JANX | Janux Therapeutics, Inc. | 877.56M | -1.51% | 754,287 | 13.73M |
| 386 | SANA | Sana Biotechnology, Inc. | 873.84M | -1.88% | 22,775,853 | - |
| 387 | TALK | Talkspace, Inc. | 869.39M | 0.19% | 1,313,440 | 238.37M |
| 388 | KURA | Kura Oncology, Inc. | 864.66M | 2.74% | 2,022,433 | 71.64M |
| 389 | ABSI | Absci Corporation | 863.71M | 4.53% | 5,265,974 | 1.84M |
| 390 | ORIC | ORIC Pharmaceuticals, Inc. | 863.34M | -3.02% | 2,736,285 | - |
| 391 | ABUS | Arbutus Biopharma Corporation | 859.29M | 0.93% | 926,160 | 191.45M |
| 392 | TBPH | Theravance Biopharma, Inc. | 851.14M | -0.96% | 386,644 | 109.78M |
| 393 | GDRX | GoodRx Holdings, Inc. | 843.30M | -4.60% | 1,996,242 | 787.89M |
| 394 | BIOA | BioAge Labs, Inc. | 831.93M | -2.22% | 340,785 | 10.32M |
| 395 | OPK | OPKO Health, Inc. | 830.60M | -0.90% | 2,058,946 | 581.12M |
| 396 | ANRO | Alto Neuroscience, Inc. | 826.89M | 3.24% | 509,839 | - |
| 397 | AURA | Aura Biosciences, Inc. | 825.02M | -0.50% | 335,596 | - |
| 398 | CTMX | CytomX Therapeutics, Inc. | 822.92M | -0.26% | 2,460,265 | 35.54M |
| 399 | ETON | Eton Pharmaceuticals, Inc. | 819.70M | -2.79% | 447,418 | 79.95M |
| 400 | EVMN | Evommune, Inc. | 818.34M | -2.45% | 266,042 | 10.00M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 817.06M | -3.46% | 356,655 | 2.98M |
| 402 | VOR | Vor Biopharma Inc. | 816.58M | -5.28% | 993,089 | - |
| 403 | SGP | SpyGlass Pharma, Inc. | 811.26M | 1.89% | 30,836 | - |
| 404 | ESPR | Esperion Therapeutics, Inc. | 803.19M | - | 18,997,394 | 418.24M |
| 405 | SSII | SS Innovations International, Inc. | 797.76M | - | 76,039 | 48.47M |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 788.45M | -0.87% | 2,403,504 | 84.28M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 778.27M | -0.93% | 423,255 | - |
| 408 | QDEL | QuidelOrtho Corporation | 776.70M | 3.08% | 2,316,097 | 2.66B |
| 409 | AZTA | Azenta, Inc. | 774.36M | -1.35% | 1,036,227 | 596.48M |
| 410 | DRUG | Bright Minds Biosciences Inc. | 763.26M | -8.21% | 365,356 | - |
| 411 | AMPH | Amphastar Pharmaceuticals, Inc. | 762.81M | -5.57% | 739,019 | 720.53M |
| 412 | SLDB | Solid Biosciences Inc. | 751.17M | 3.39% | 1,543,712 | - |
| 413 | ALLO | Allogene Therapeutics, Inc. | 738.63M | -8.15% | 9,164,460 | 22.00K |
| 414 | CERT | Certara, Inc. | 717.15M | -3.76% | 5,551,790 | 419.75M |
| 415 | EIKN | Eikon Therapeutics, Inc. | 713.55M | 7.07% | 441,067 | - |
| 416 | EHAB | Enhabit, Inc. | 706.91M | 0.07% | 1,382,540 | 1.06B |
| 417 | CBIO | Crescent Biopharma, Inc. | 705.45M | 8.26% | 171,819 | 11.88M |
| 418 | PSNL | Personalis, Inc. | 702.68M | 5.01% | 3,392,927 | 64.52M |
| 419 | TENX | Tenax Therapeutics, Inc. | 700.65M | -0.08% | 348,383 | - |
| 420 | LMRI | Lumexa Imaging Holdings, Inc. | 692.74M | -10.43% | 2,687,240 | 1.03B |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 689.28M | 4.86% | 3,090,790 | 122.29M |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 681.08M | 5.32% | 343,230 | - |
| 423 | ACRS | Aclaris Therapeutics, Inc. | 670.39M | -5.70% | 2,215,621 | 8.37M |
| 424 | BWAY | BrainsWay Ltd. | 665.08M | 0.06% | 232,944 | 56.22M |
| 425 | HSTM | HealthStream, Inc. | 664.21M | -0.68% | 194,764 | 311.78M |
| 426 | TLRY | Tilray Brands, Inc. | 656.06M | 0.73% | 2,834,454 | 858.28M |
| 427 | CADL | Candel Therapeutics, Inc. | 652.84M | -0.34% | 3,024,835 | - |
| 428 | KYTX | Kyverna Therapeutics, Inc. | 650.10M | -0.37% | 912,770 | - |
| 429 | SIBN | SI-BONE, Inc. | 647.50M | 3.11% | 861,058 | 206.22M |
| 430 | GYRE | Gyre Therapeutics, Inc. | 639.60M | -3.85% | 213,266 | 117.05M |
| 431 | STRO | Sutro Biopharma, Inc. | 636.54M | -2.98% | 117,413 | 102.48M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 631.04M | -1.47% | 211,550 | - |
| 433 | AVR | Anteris Technologies Global Corp. | 628.60M | 11.03% | 1,547,254 | 1.85M |
| 434 | CBLL | CeriBell, Inc. | 623.40M | -8.26% | 474,497 | 95.07M |
| 435 | CRMD | CorMedix Inc. | 622.05M | 5.73% | 4,321,451 | 400.05M |
| 436 | ARVN | Arvinas, Inc. | 607.79M | -4.56% | 1,059,975 | 89.40M |
| 437 | FBRX | Forte Biosciences, Inc. | 607.66M | -2.84% | 127,447 | - |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 604.13M | -0.27% | 2,425,086 | 361.51M |
| 439 | AQST | Aquestive Therapeutics, Inc. | 593.38M | 14.53% | 5,849,660 | 50.27M |
| 440 | RIGL | Rigel Pharmaceuticals, Inc. | 590.59M | -0.65% | 450,657 | 299.77M |
| 441 | CABA | Cabaletta Bio, Inc. | 588.61M | 0.56% | 3,280,920 | - |
| 442 | CSTL | Castle Biosciences, Inc. | 572.63M | 4.02% | 652,475 | 339.92M |
| 443 | ALT | Altimmune, Inc. | 567.86M | -3.31% | 2,388,259 | 36.00K |
| 444 | VALN | Valneva SE | 567.81M | 1.87% | 47,722 | 180.25M |
| 445 | PRME | Prime Medicine, Inc. | 565.33M | -4.28% | 2,244,191 | 4.03M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 562.30M | 3.44% | 234,914 | - |
| 447 | ANL | Adlai Nortye Ltd. | 554.40M | -0.57% | 122,175 | 5.00M |
| 448 | AGMB | AgomAb Therapeutics NV | 543.70M | -1.25% | 123,899 | - |
| 449 | CLYM | Climb Bio, Inc. | 541.22M | -0.70% | 435,755 | - |
| 450 | NPCE | NeuroPace, Inc. | 538.51M | -0.09% | 123,673 | 99.53M |
| 451 | IMMX | Immix Biopharma, Inc. | 535.42M | -3.72% | 759,864 | - |
| 452 | PHR | Phreesia, Inc. | 532.89M | -4.57% | 1,886,304 | 480.59M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 531.26M | 0.42% | 97,309 | - |
| 454 | MDXG | MiMedx Group, Inc. | 528.76M | 0.85% | 1,106,522 | 389.42M |
| 455 | XOMA | XOMA Royalty Corporation | 526.35M | 0.41% | 162,820 | 48.56M |
| 456 | TCMD | Tactile Systems Technology, Inc. | 519.70M | -1.07% | 231,789 | 343.52M |
| 457 | PROK | ProKidney Corp. | 516.35M | -2.29% | 1,110,453 | 893.00K |
| 458 | PRTA | Prothena Corporation plc | 516.20M | 2.71% | 452,435 | 57.94M |
| 459 | FDMT | 4D Molecular Therapeutics, Inc. | 512.83M | -6.12% | 428,753 | 88.24M |
| 460 | DNA | Ginkgo Bioworks Holdings, Inc. | 512.80M | -8.61% | 1,060,916 | 151.40M |
| 461 | AVTX | Avalo Therapeutics, Inc. | 507.84M | -4.23% | 1,706,659 | 59.00K |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 463 | STTK | Shattuck Labs, Inc. | 504.13M | -1.19% | 413,730 | 1.00M |
| 464 | CERS | Cerus Corporation | 502.93M | -3.46% | 2,352,681 | 216.56M |
| 465 | OFIX | Orthofix Medical Inc. | 496.78M | 0.66% | 237,214 | 825.37M |
| 466 | OCGN | Ocugen, Inc. | 494.23M | -0.68% | 4,238,647 | 4.47M |
| 467 | NGNE | Neurogene Inc. | 494.13M | -4.14% | 122,168 | 925.00K |
| 468 | OVID | Ovid Therapeutics Inc. | 484.50M | - | 1,324,026 | 7.12M |
| 469 | ASMB | Assembly Biosciences, Inc. | 481.55M | -4.48% | 69,452 | 71.10M |
| 470 | UPB | Upstream Bio, Inc. | 478.35M | -6.09% | 496,606 | 3.32M |
| 471 | VTVT | vTv Therapeutics Inc. | 476.90M | 21.35% | 147,575 | 36.84M |
| 472 | FULC | Fulcrum Therapeutics, Inc. | 473.76M | -1.93% | 501,071 | 80.00M |
| 473 | SRTA | Strata Critical Medical, Inc. | 473.30M | 0.74% | 1,040,339 | 228.58M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 469.20M | -5.17% | 131,956 | - |
| 475 | KMDA | Kamada Ltd. | 465.11M | 2.10% | 68,051 | 180.46M |
| 476 | EVH | Evolent Health, Inc. | 461.17M | -0.73% | 2,332,981 | 1.89B |
| 477 | FLGT | Fulgent Genetics, Inc. | 459.81M | 1.44% | 462,148 | 320.35M |
| 478 | KIDS | OrthoPediatrics Corp. | 459.76M | 0.62% | 204,692 | 243.30M |
| 479 | ANGO | AngioDynamics, Inc. | 459.75M | 1.75% | 288,252 | 313.73M |
| 480 | ZURA | Zura Bio Limited | 458.27M | 0.63% | 238,800 | - |
| 481 | SGMT | Sagimet Biosciences Inc. | 455.11M | -3.03% | 684,130 | - |
| 482 | PRLD | Prelude Therapeutics Incorporated | 449.58M | -4.08% | 263,457 | 16.72M |
| 483 | LYEL | Lyell Immunopharma, Inc. | 443.78M | -1.14% | 37,593 | 31.00K |
| 484 | PRTC | PureTech Health plc | 442.35M | 2.57% | 4,275 | 4.66M |
| 485 | CATX | Perspective Therapeutics, Inc. | 440.22M | 1.05% | 840,802 | 618.00K |
| 486 | EOLS | Evolus, Inc. | 433.32M | -2.08% | 490,450 | 301.79M |
| 487 | CTKB | Cytek Biosciences, Inc. | 433.27M | -8.83% | 2,533,487 | 204.17M |
| 488 | LXEO | Lexeo Therapeutics, Inc. | 431.87M | -4.51% | 424,429 | - |
| 489 | IPSC | Century Therapeutics, Inc. | 429.24M | 4.39% | 756,909 | 109.16M |
| 490 | ADCT | ADC Therapeutics SA | 427.36M | -3.45% | 903,984 | 79.18M |
| 491 | NRC | NRC Health | 426.62M | 1.39% | 88,658 | 138.64M |
| 492 | CCRN | Cross Country Healthcare, Inc. | 424.53M | 0.08% | 1,182,795 | 1.00B |
| 493 | EBS | Emergent BioSolutions Inc. | 423.61M | -1.44% | 598,714 | 676.80M |
| 494 | AUTL | Autolus Therapeutics plc | 423.17M | -7.02% | 2,996,641 | 75.39M |
| 495 | VREX | Varex Imaging Corporation | 422.31M | -0.50% | 595,609 | 857.50M |
| 496 | VSTM | Verastem, Inc. | 413.88M | -0.21% | 1,740,114 | 49.59M |
| 497 | CGC | Canopy Growth Corporation | 410.40M | -1.83% | 6,776,374 | 203.04M |
| 498 | BBNX | Beta Bionics, Inc. | 409.97M | -4.47% | 611,254 | 110.24M |
| 499 | WEAV | Weave Communications, Inc. | 409.76M | -0.77% | 923,491 | 248.72M |
| 500 | MNPR | Monopar Therapeutics Inc. | 408.56M | -0.73% | 483,812 | - |